Our Services
Medical Information
Helpful Resources
Published on: 9/16/2026
Yes, trazodone can cause dizziness, lightheadedness, and an increased risk of falls in older women, largely due to orthostatic hypotension (a drop in blood pressure when standing), sedation, and slowed reaction time that can linger into the morning. Risk rises with higher doses, dehydration, and combined use of blood pressure medications, other sedatives, or alcohol, and older women may be especially vulnerable because of lower body weight, slower drug clearance, and reduced bone density that makes a fall more likely to result in fracture. Several important details, including warning signs, dose timing, and safer alternatives worth discussing with a clinician, are outlined below.
If you or someone you care for feels unsteady, foggy, or faint after starting or adjusting trazodone, it helps to sort out whether the medication, blood pressure, inner ear, or another cause is driving it before the next stumble happens. A free, instant, online symptom check asks targeted questions about your symptoms, medications, and health history, then suggests possible causes and the right level of care so you can walk into your next appointment prepared rather than guessing. It takes only a few minutes, requires no signup, and can help you decide whether this warrants a call to your prescriber today or a routine follow-up.
Last reviewed for medical accuracy: 09/15/2026
Trazadone and the Risk of Dizziness and Falls in Older Women
Trazadone (often spelled “Trazadone” in online searches) is an antidepressant in the serotonin modulator class. Although it’s FDA-approved for depression, it’s frequently prescribed off-label at lower doses to help with insomnia. In older women, concerns about side effects such as dizziness and falls are particularly important. This article reviews what the research says, why older women may be more vulnerable, and practical steps you can take to reduce risk.
Why Dizziness and Falls Matter
• Falls are a leading cause of injury, hospitalization and loss of independence in older adults.
• Even a single fall can trigger fear of walking, social withdrawal and a cascade of health declines.
• Dizziness and lightheadedness are common side effects of many medications in seniors, and Trazadone is no exception.
How Trazadone Can Cause Dizziness
Trazadone’s chemical actions can lead to:
• Orthostatic hypotension (a drop in blood pressure when standing up)
• Sedation and slowed reflexes
• Anticholinergic effects (dry mouth, blurred vision, which can affect balance)
Orthostatic Hypotension
• Trazadone blocks certain alpha-adrenergic receptors in blood vessels.
• This can prevent the vessels from tightening when you stand, causing blood to pool in your legs and your blood pressure to drop.
• Symptoms include lightheadedness, dizziness, even fainting.
Sedation and Impaired Coordination
• Trazadone has sedating effects, especially at higher doses.
• Drowsiness and delayed reaction time increase the chance of a misstep.
• Nighttime dosing for insomnia may lead to morning grogginess, raising fall risk during early activities.
Who Is Most at Risk?
Age alone isn’t the only factor. Other contributors include:
• Dose of Trazadone: Higher doses (150 mg or above) tend to cause more hypotension and sedation.
• Multiple Medications: Combining Trazadone with blood pressure drugs, diuretics or other sedatives magnifies risk.
• Pre-existing Conditions: Parkinson’s disease, diabetes with neuropathy, anemia, dehydration and balance disorders all add up.
• History of Falls: Past falls strongly predict future falls.
• Rapid Dose Changes: Starting at a usual adult dose rather than “start low, go slow” can overwhelm an older person’s system.
What Does the Research Show?
Several credible sources and studies highlight the issue:
• American Geriatrics Society Beers Criteria lists Trazadone as a medication that can cause orthostatic hypotension in older adults.
• A 2015 observational study in geriatric psychiatry journals found that seniors on Trazadone had a 1.4-fold increased risk of falls compared to those on non-hypotensive antidepressants.
• Post-marketing reports to the FDA underscore dizziness and syncope as common adverse events, particularly in patients over 65.
Balancing Benefits and Risks
Trazadone is appealing for insomnia because it’s inexpensive and generally well-tolerated at low doses. But in older women, the risks of dizziness and falls must be weighed against sleep improvement. Consider these questions with your provider:
• Is insomnia severe enough to warrant medication?
• Have non-drug approaches (sleep hygiene, CBT-I) been fully tried?
• What’s the lowest effective dose of Trazadone?
• Could a non-sedating antidepressant or sleep aid be safer?
Practical Strategies to Reduce Dizziness and Fall Risk
When to Seek Help
If you experience any of the following, reach out promptly:
• Fainting or near-fainting spells
• Repeated dizziness or imbalance
• Injuries from a fall (bruises, fractures or head bumps)
• New or worsening heart palpitations
You may also consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker to get personalized guidance before your appointment.
Alternative Approaches to Insomnia
If Trazadone’s side effects outweigh its benefits, talk with your doctor about:
• Cognitive Behavioral Therapy for Insomnia (CBT-I)
• Melatonin or melatonin receptor agonists (e.g., ramelteon)
• Low-dose doxepin (under careful monitoring)
• Optimizing sleep hygiene: consistent schedule, reducing caffeine/alcohol, proper bedroom environment
Key Takeaways
• Trazadone can cause orthostatic hypotension and sedation, leading to dizziness and falls in older women.
• Risk factors include higher doses, polypharmacy, existing balance issues and a history of falls.
• Strategies such as “start low, go slow,” blood pressure monitoring and home safety improvements can help.
• Always balance the potential sleep benefits against safety risks.
• Consider non-drug options and discuss alternatives with your doctor.
Remember, this information is not a substitute for professional medical advice. Always speak to a healthcare provider about any side effects or concerns—especially if you experience serious or life-threatening symptoms. Regular follow-up and open communication with your doctor or pharmacist are essential to staying safe and well.
(References)
* Feighner JP. Mechanism of action of antidepressant medications. J Clin Psychiatry. 1999;60 Suppl 4:4-11; discussion 12-3. PMID: 10086478.
* Atkin T, Comai S, Gobbi G. Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery. Pharmacol Rev. 2018 Apr;70(2):197-245. doi: 10.1124/pr.117.014381. PMID: 29487083.
* Abad VC, Guilleminault C. Insomnia in Elderly Patients: Recommendations for Pharmacological Management. Drugs Aging. 2018 Sep;35(9):791-817. doi: 10.1007/s40266-018-0569-8. PMID: 30058034.
* Schwasinger-Schmidt TE, Macaluso M. Other Antidepressants. Handb Exp Pharmacol. 2019;250:325-355. doi: 10.1007/164_2018_167. PMID: 30194544.
* McElroy H, O'Leary B, Adena M, Campbell R, Monfared AAT, Meier G. Comparative efficacy of lemborexant and other insomnia treatments: a network meta-analysis. J Manag Care Spec Pharm. 2021 Sep;27(9):1296-1308. doi: 10.18553/jmcp.2021.21011. Epub 2021 Jun 12. PMID: 34121443; PMCID: PMC10394202.
* Calvi A, Fischetti I, Verzicco I, Belvederi Murri M, Zanetidou S, Volpi R, Coghi P, Tedeschi S, Amore M, Cabassi A. Antidepressant Drugs Effects on Blood Pressure. Front Cardiovasc Med. 2021;8:704281. doi: 10.3389/fcvm.2021.704281. Epub 2021 Aug 3. PMID: 34414219; PMCID: PMC8370473.
* Sharma KD, Colangelo T, Mills A. Trazodone-induced parkinsonism: A case report. Int J Clin Pharmacol Ther. 2022 Apr;60(4):184-187. doi: 10.5414/CP204068. PMID: 35102822.
* Coin A, Malara A, Noale M, Trevisan C, Devita M, Abbatecola AM, Gareri P, Del Signore S, Bellelli G, Fumagalli S, Monzani F, Mossello E, Volpato S, Zia G, Antonelli Incalzi R, GeroCovid Observational Working Group. Real-World Use of Trazodone in Older Persons in Long Term Care Setting: A Retrospective Study. Int J Geriatr Psychiatry. 2024 Nov;39(11):e70009. doi: 10.1002/gps.70009. PMID: 39482555.
* Chrobak AA, Woroń J, Siwek M. Green rush and red warnings: Retrospective chart review of adverse events of interactions between cannabinoids and psychotropic drugs. Front Pharmacol. 2024;15:1500312. doi: 10.3389/fphar.2024.1500312. Epub 2024 Oct 22. PMID: 39502532; PMCID: PMC11534596.
* Hui RL, Lee AL, Lee EA, Lee RS, Niu F. Safety of Low-Dose Quetiapine for Insomnia in Older Adults. Drugs Aging. 2025 Feb;42(2):127-133. doi: 10.1007/s40266-024-01170-5. Epub 2025 Jan 2. PMID: 39747780.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.